NO940028L - - Google Patents
Info
- Publication number
- NO940028L NO940028L NO940028A NO940028A NO940028L NO 940028 L NO940028 L NO 940028L NO 940028 A NO940028 A NO 940028A NO 940028 A NO940028 A NO 940028A NO 940028 L NO940028 L NO 940028L
- Authority
- NO
- Norway
- Prior art keywords
- alkyl
- formula
- group
- hydrogen
- phenyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
- C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
- C07D221/22—Bridged ring systems
- C07D221/28—Morphinans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Hospice & Palliative Care (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Psychiatry (AREA)
- Emergency Medicine (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Saccharide Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US113593A | 1993-01-06 | 1993-01-06 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO940028D0 NO940028D0 (no) | 1994-01-04 |
| NO940028L true NO940028L (OSRAM) | 1994-07-07 |
Family
ID=21694554
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO940028A NO940028D0 (no) | 1993-01-06 | 1994-01-04 | O-aryletere av morfinaner |
Country Status (23)
| Country | Link |
|---|---|
| EP (1) | EP0612730B1 (OSRAM) |
| JP (1) | JP2501298B2 (OSRAM) |
| KR (1) | KR940018094A (OSRAM) |
| CN (1) | CN1097006A (OSRAM) |
| AT (1) | ATE154931T1 (OSRAM) |
| AU (1) | AU681601B2 (OSRAM) |
| BR (1) | BR9400021A (OSRAM) |
| CA (1) | CA2110337A1 (OSRAM) |
| CZ (1) | CZ2294A3 (OSRAM) |
| DE (1) | DE69311887T2 (OSRAM) |
| DK (1) | DK0612730T3 (OSRAM) |
| ES (1) | ES2105061T3 (OSRAM) |
| FI (1) | FI940041L (OSRAM) |
| GR (1) | GR3024891T3 (OSRAM) |
| HU (2) | HUT66061A (OSRAM) |
| IL (1) | IL108247A (OSRAM) |
| MX (1) | MX9400177A (OSRAM) |
| NO (1) | NO940028D0 (OSRAM) |
| NZ (1) | NZ250580A (OSRAM) |
| PL (1) | PL175365B1 (OSRAM) |
| TW (1) | TW264473B (OSRAM) |
| UY (1) | UY23706A1 (OSRAM) |
| ZA (1) | ZA939806B (OSRAM) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9522176D0 (en) * | 1995-10-30 | 1996-01-03 | Iaf Biochem Int | Morphinan derivatives having neuroprotective activity |
| EP1384720A1 (en) * | 1996-06-13 | 2004-01-28 | SUMIKA FINE CHEMICALS Co., Ltd. | Process for drying paroxetine hydrochloride |
| FR2752163B1 (fr) * | 1996-08-12 | 1998-10-30 | Pf Medicament | Utilisation de l'efaroxan pour la fabricaton de medicament destine au traitement de la maladie de huntington |
| GB9706753D0 (en) * | 1997-04-03 | 1997-05-21 | Pharmacia & Upjohn Spa | Aralkoxy-morphinan derivatives |
| KR100425881B1 (ko) * | 2001-03-14 | 2004-04-03 | 고광호 | 신규한 몰피난 유도체 |
| CN103405431B (zh) * | 2002-05-17 | 2016-04-13 | 台湾J药品有限公司 | 阿片和阿片样化合物及其用途 |
| DE10229842A1 (de) * | 2002-07-03 | 2004-02-05 | Helmut Prof. Dr. Schmidhammer | Morphinanderivate und deren quartäre Ammoniumsalze substituiert in Position 14, Herstellungsverfahren und Verwendung |
| US20040204862A1 (en) | 2003-04-11 | 2004-10-14 | Wainer Irving W. | Computer-based model for identification and characterization for non-competitive inhibitors of nicotinic acetylcholine receptors and related ligand-gated ion channel receptors |
| US8017622B2 (en) | 2003-05-16 | 2011-09-13 | Jenken Biosciences, Inc. | Opioid and opioid-like compounds and uses thereof |
| CN102325776A (zh) * | 2009-02-23 | 2012-01-18 | 马林克罗特公司 | (+)-吗啡喃*季盐及其制备方法 |
| CN103044327B (zh) * | 2013-01-07 | 2014-12-17 | 苏州立新制药有限公司 | 一种右美沙芬的制备方法 |
| KR20170052684A (ko) * | 2014-09-14 | 2017-05-12 | 아바니르 파마슈티컬스, 인코포레이티드 | 치매에서의 초조함을 치료하기 위한 덱스트로메토르판 화합물 및 퀴니딘을 포함하는 약제학적 조성물 |
| US20160243112A1 (en) * | 2015-02-25 | 2016-08-25 | Alkermes, Inc. | Treatments for alzheimer's related diseases and disorders |
| WO2022045301A1 (ja) * | 2020-08-28 | 2022-03-03 | 日本ケミファ株式会社 | 新規銅触媒を用いたジアリールエーテル骨格を有するモルヒナン誘導体の製造方法 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FI773636A7 (fi) * | 1976-12-06 | 1978-06-07 | Hoffmann La Roche | Nya fenylderivat |
| US4113729A (en) * | 1976-12-06 | 1978-09-12 | Hoffmann-La Roche Inc. | 3-Phenoxymorphinans and derivatives thereof |
| US4806543A (en) * | 1986-11-25 | 1989-02-21 | Board Of Trustees Of The Leland Stanford Junior University | Method and compositions for reducing neurotoxic injury |
-
1993
- 1993-11-25 TW TW082109942A patent/TW264473B/zh active
- 1993-11-30 CA CA002110337A patent/CA2110337A1/en not_active Abandoned
- 1993-12-20 DK DK93120498.6T patent/DK0612730T3/da active
- 1993-12-20 ES ES93120498T patent/ES2105061T3/es not_active Expired - Lifetime
- 1993-12-20 AT AT93120498T patent/ATE154931T1/de not_active IP Right Cessation
- 1993-12-20 DE DE69311887T patent/DE69311887T2/de not_active Expired - Fee Related
- 1993-12-20 EP EP93120498A patent/EP0612730B1/en not_active Expired - Lifetime
- 1993-12-23 NZ NZ250580A patent/NZ250580A/en unknown
- 1993-12-30 ZA ZA939806A patent/ZA939806B/xx unknown
- 1993-12-30 JP JP5354172A patent/JP2501298B2/ja not_active Expired - Lifetime
- 1993-12-31 UY UY23706A patent/UY23706A1/es unknown
- 1993-12-31 IL IL108247A patent/IL108247A/en not_active IP Right Cessation
- 1993-12-31 AU AU52807/93A patent/AU681601B2/en not_active Ceased
-
1994
- 1994-01-03 MX MX9400177A patent/MX9400177A/es not_active IP Right Cessation
- 1994-01-03 HU HU9400002A patent/HUT66061A/hu unknown
- 1994-01-04 NO NO940028A patent/NO940028D0/no unknown
- 1994-01-04 KR KR1019940000067A patent/KR940018094A/ko not_active Ceased
- 1994-01-05 CZ CZ9422A patent/CZ2294A3/cs unknown
- 1994-01-05 FI FI940041A patent/FI940041L/fi unknown
- 1994-01-05 BR BR9400021A patent/BR9400021A/pt not_active Application Discontinuation
- 1994-01-05 PL PL94301784A patent/PL175365B1/pl unknown
- 1994-01-05 CN CN94100181A patent/CN1097006A/zh active Pending
-
1995
- 1995-06-19 HU HU95P/P00253P patent/HU211290A9/hu unknown
-
1997
- 1997-09-30 GR GR970402538T patent/GR3024891T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN1097006A (zh) | 1995-01-04 |
| AU5280793A (en) | 1994-07-14 |
| FI940041A7 (fi) | 1994-07-07 |
| DK0612730T3 (da) | 1998-02-02 |
| CZ2294A3 (en) | 1994-07-13 |
| BR9400021A (pt) | 1994-07-26 |
| HU9400002D0 (en) | 1994-05-30 |
| KR940018094A (ko) | 1994-08-16 |
| ES2105061T3 (es) | 1997-10-16 |
| UY23706A1 (es) | 1994-06-05 |
| TW264473B (OSRAM) | 1995-12-01 |
| HUT66061A (en) | 1994-09-28 |
| IL108247A (en) | 1998-02-22 |
| CA2110337A1 (en) | 1994-07-07 |
| NZ250580A (en) | 1996-07-26 |
| EP0612730A1 (en) | 1994-08-31 |
| EP0612730B1 (en) | 1997-07-02 |
| FI940041L (fi) | 1994-07-07 |
| AU681601B2 (en) | 1997-09-04 |
| NO940028D0 (no) | 1994-01-04 |
| JP2501298B2 (ja) | 1996-05-29 |
| FI940041A0 (fi) | 1994-01-05 |
| DE69311887D1 (de) | 1997-08-07 |
| MX9400177A (es) | 1994-07-29 |
| HU211290A9 (en) | 1995-11-28 |
| GR3024891T3 (en) | 1998-01-30 |
| IL108247A0 (en) | 1994-04-12 |
| DE69311887T2 (de) | 1998-01-15 |
| ZA939806B (en) | 1994-07-06 |
| ATE154931T1 (de) | 1997-07-15 |
| PL301784A1 (en) | 1994-07-11 |
| PL175365B1 (pl) | 1998-12-31 |
| JPH06316564A (ja) | 1994-11-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO940028L (OSRAM) | ||
| CA2073981A1 (en) | 2-arylthiazole derivatives and pharmaceutical composition thereof | |
| NO180540B (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktiv cyklisk amidderivat | |
| ATE157368T1 (de) | 6-0-methylerythromycin a-derivat | |
| PT870765E (pt) | Derivados de aminotiazole drogas contendo os mesmos e intermediarios na producao dos compostos | |
| DE69133277D1 (de) | Chelat-zubereitungen, die oximverbindungen enthalten | |
| MY107611A (en) | Isoxazole derivatives. | |
| AU2001272666A1 (en) | 2-adamantylethylamines and their use in the treatment of conditions generally associated with abnormalities in glutamatergic transmission | |
| AU2097492A (en) | Composition and method for treating cancer | |
| AU6572896A (en) | Enantiomerically enriched thiazolidine or oxazolidine compounds | |
| KR880002829A (ko) | 디하이드로피리딘 항알러지제 및 소염제 | |
| NO922604L (no) | Pyrrolopyraziner | |
| ES474232A1 (es) | Un metodo para producir 2,6-diaminonebularinas | |
| SE8207092L (sv) | Forfarande for framstellning av optiskt aktiva penemer | |
| GB9901691D0 (en) | Chemical compounds | |
| AU1855088A (en) | Treating agent for heart failure | |
| KR950014111A (ko) | 새로운 카바페넴 유도체 및 그 제조방법 | |
| SE8403168D0 (sv) | Carboxylic acid amide compounds and their derivatives | |
| RU93057749A (ru) | О-арил эфиры морфинанов | |
| ES428442A1 (es) | Un procedimiento para la preparacion de derivados de 1, 2, 3, 4-tetrahidroisoquinoleina. | |
| AU1287892A (en) | Method of inhibiting the progressive development of diabetes mellitus | |
| ECSP951498A (es) | Nuevos derivados de pirrocarbazol case ran 4121/15 | |
| NO885081D0 (no) | Labile keton-derivater av 3-substituerte 1-alkylamino - 2- propanoler og anvendelse som beta-adrenergiske blokkere. | |
| KR940002252A (ko) | 우수한 항균작용을 갖는 신규한 피리돈 카르복실산 유도체 및 그의 제조방법 | |
| CA2359031A1 (en) | Thiazolidinone or oxazolidinone derivatives for treatment of ulcerative disease |